Advanced Diagnostic Support for Major Chest Diseases
aview LCS Plus is an innovative solution with advanced AI designed to identify and analyze major chest diseases.
It is characterized by the detection of small lung nodules that can potentially lead to lung cancer, the assessment of damage to the lung parenchyma and the identification of coronary artery calcification.
As this diagnostic tool offers the possibility of detecting and analyzing several breast diseases simultaneously, it is very effective both for initial screening and for ongoing follow-up care.
The system interprets low-dose chest CT images to analyze and report on emphysema, offering comprehensive and automated reporting.
It also processes low-dose chest CT images to detect and analyze lung nodules, providing automated reporting for efficient diagnosis.
It efficiently identifies calcification in coronary arteries using low-dose chest CT images and automatically reports the findings.
LCS Plus is a trusted solution in global lung cancer screening projects.
See Lung Cancer with an AI
Automated Coronary Artery Calcium and Quantitative Emphysema in Lung Cancer Screening
Association With Mortality, Lung Cancer Incidence, and Airflow Obstruction
